Grant✓ Small businesses may apply
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
National Institutes of Health
Award ceiling
$500,000
Program funding
$500,000
- Opportunity #
- PAR-25-175
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.393, 93.395, 93.394
- Status
- posted
- Posted
- Nov 6, 2024
- Closes
- Jan 7, 2028
- Funding instrument
- Grant
- Category
- Education, Health
- Cost sharing required
- No
Who can apply
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Public housing authorities/Indian housing authorities
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •State governments
- •County governments
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Private institutions of higher education
- •Special district governments
- •Small businesses
- •Public and State controlled institutions of higher education
- •For profit organizations other than small businesses
- •City or township governments
- •Independent school districts
- •Native American tribal governments (Federally recognized)
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Synopsis
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.
Contact
National Institutes of Health · grantsinfo@nih.gov